ArticleClinical immunology (Orlando, Fla.)2021

Development of highly stable and de-immunized versions of recombinant alpha interferon: Promising candidates for the treatment of chronic and emerging viral diseases.

Sofía Inés Giorgetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.